Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan Maisel

Showing results (51-60 of 148) with videos related to

Pageof 15
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 16, 2026
Admission Kidney Tubule Biomarkers Do Not Predict Acute Kidney Injury or In-Hospital Adverse Events in Acute Heart FailureStephen Duff, Nicholas Wettersten, Yu Horiuchi, et al.
Journal of Cardiac Failure|March 6, 2012
Differentiation of cardiac and noncardiac dyspnea using bioelectrical impedance vector analysis (BIVA)Antonio Piccoli, Marta Codognotto, Vito Cianci, et al.
Diabetes Care|July 2, 2003
Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetesVictoria Epshteyn, Katherine Morrison, Padma Krishnaswamy, et al.
The American Journal of Cardiology|February 7, 2012
Cardiac biomarkers, mortality, and post-traumatic stress disorder in military veteransYang Xue, Pam R Taub, Navaid Iqbal, et al.
Revista Espanola De Cardiologia|September 30, 2010
Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failureAntoni Bayes-Genis, Domingo Pascual-Figal, James L Januzzi, et al.
American Heart Journal|January 24, 2007
The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal diseaseVictoria Sheen, Vikas Bhalla, Alisi Tulua-Tata, et al.
The American Journal of Cardiology|February 29, 2020
N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study of Atherosclerosis [MESA])Khoa Nguyen, Wenjun Fan, Alain Bertoni, et al.
Journal of Cardiac Failure|November 30, 2014
The potential role of natriuretic peptide-guided management for patients hospitalized for heart failureAlan Maisel, Yang Xue, Stephen J Greene, et al.
Critical Pathways in Cardiology|September 4, 2009
Low-risk acute heart failure patients: external validation of the Society of Chest Pain Center's recommendationsSean P Collins, Christopher J Lindsell, Allen J Naftilan, et al.
Journal of Cardiac Failure|May 30, 2009
The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF studyIrene Betti, Gabriele Castelli, Alessandro Barchielli, et al.
Pageof 15

Showing results (51-60 of 148) with videos related to

Sort By:
Pageof 15
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 16, 2026
Admission Kidney Tubule Biomarkers Do Not Predict Acute Kidney Injury or In-Hospital Adverse Events in Acute Heart FailureStephen Duff, Nicholas Wettersten, Yu Horiuchi, et al.
Journal of Cardiac Failure|March 6, 2012
Differentiation of cardiac and noncardiac dyspnea using bioelectrical impedance vector analysis (BIVA)Antonio Piccoli, Marta Codognotto, Vito Cianci, et al.
Diabetes Care|July 2, 2003
Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetesVictoria Epshteyn, Katherine Morrison, Padma Krishnaswamy, et al.
The American Journal of Cardiology|February 7, 2012
Cardiac biomarkers, mortality, and post-traumatic stress disorder in military veteransYang Xue, Pam R Taub, Navaid Iqbal, et al.
Revista Espanola De Cardiologia|September 30, 2010
Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failureAntoni Bayes-Genis, Domingo Pascual-Figal, James L Januzzi, et al.
American Heart Journal|January 24, 2007
The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal diseaseVictoria Sheen, Vikas Bhalla, Alisi Tulua-Tata, et al.
The American Journal of Cardiology|February 29, 2020
N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study of Atherosclerosis [MESA])Khoa Nguyen, Wenjun Fan, Alain Bertoni, et al.
Journal of Cardiac Failure|November 30, 2014
The potential role of natriuretic peptide-guided management for patients hospitalized for heart failureAlan Maisel, Yang Xue, Stephen J Greene, et al.
Critical Pathways in Cardiology|September 4, 2009
Low-risk acute heart failure patients: external validation of the Society of Chest Pain Center's recommendationsSean P Collins, Christopher J Lindsell, Allen J Naftilan, et al.
Journal of Cardiac Failure|May 30, 2009
The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF studyIrene Betti, Gabriele Castelli, Alessandro Barchielli, et al.
Pageof 15